戻る
Tandem Diabetes Care Inc (TNDM)価格
TNDM 株価推移チャート
TNDM 収入
Tandem Diabetes Care Inc
$20.2
1.5%
$0.3
終値： Jan 26, 16:00:00 GMT-5
$20.2
0%
$0
アフターマーケット：Jan 26, 18:01:04 GMT-5
最新の利益結果: Q3 '25
報告済み: 2025-11-06
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
TNDMの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Tandem Diabetes Care Inc TNDMの前四半期の収益はどうでしたか？
Tandem Diabetes Care Incの収益見積もりはいくらですか？
Tandem Diabetes Care Incの収益品質スコアはどれくらいですか？
Tandem Diabetes Care Incはいつ収益を報告しますか？
Tandem Diabetes Care Incの予想収益はいくらですか？
Tandem Diabetes Care Incは収益予想を上回りましたか？
主要データ
前終値
$19.9
始値
$19.75
当日レンジ
$19.75 - $20.52
52週レンジ
$9.98 - $37.93
取引高
689.2K
平均取引高
1.9M
1株当たり利益(TTM)
-3.49
配当利回り
--
時価総額
$1.3B
TNDMとは何ですか？
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. The company is headquartered in San Diego, California and currently employs 2,650 full-time employees. The company went IPO on 2013-11-13. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.